Podoplanin expression in various types of oral dysplasia and oral squamous cell carcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Podoplanin (PDPN) expression increases with oral dysplasia and oral squamous cell carcinoma (OSCC) progression. PDPN may serve as a prognostic marker for OSCC, aiding treatment strategies.
Area Of Science
- Oncology
- Pathology
- Biomarker Research
Background
- Oral leukoplakia and oral squamous cell carcinoma (OSCC) are significant oral health concerns.
- Accurate prognostic markers are crucial for effective OSCC management and treatment planning.
Purpose Of The Study
- To investigate the role of podoplanin (PDPN) in oral leukoplakia and OSCC.
- To evaluate PDPN as a potential marker for malignant development, progression, and prognosis in OSCC.
- To correlate PDPN expression with the extent of tumor invasion in OSCC.
Main Methods
- Immunohistochemical analysis of PDPN was performed on 77 oral tissue samples.
- Samples included various grades of OSCC invasion and dysplasia.
- Statistical analysis using Fisher's exact test and Kruskal-Wallis test was employed.
Main Results
- PDPN staining scores increased progressively from mild dysplasia to carcinoma in situ.
- Highest PDPN overexpression was observed in well-differentiated OSCC.
- Significant associations were found between PDPN expression and sample type, intensity, distribution, and lymphatic vessel involvement (p < 0.05).
Conclusions
- PDPN expression correlates with the progression of oral dysplasia and OSCC.
- PDPN may serve as a valuable prognostic biomarker for OSCC.
- Understanding PDPN's role can inform improved prognostic accuracy and treatment strategies for OSCC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.